Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label rollover study of cenicriviroc in adult subjects with nonalcoholic steatohepatitis (NASH) and liver fibrosis
2016-004754-15Phase 2Unknown
- Sponsor
- Allergan
- Start
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cenicriviroc in metabolic dysfunction-associated steatohepatitis (MASH), hepatic fibrosis, sponsored by Allergan. Status: unknown.
02
Drugs
cenicriviroc
03
Conditions
metabolic dysfunction-associated steatohepatitis (MASH)hepatic fibrosis
Beyond the preview
Go deeper on 2016-004754-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004754-15.